Erectile Dysfunction: Clinical Trials

111 trials for Erectile Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

79 completed, 17 unknown, 5 recruiting, 4 terminated. 111 Phase 3, 10 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 3111Completed 79, Unknown 17, Recruiting 5, Terminated 4, Not yet recruiting 3, Active not recruiting 2, Withdrawn 1
Phase 210Completed 4, Recruiting 3, Unknown 3

Follow Erectile Dysfunction: new trials by email Literature Review of Erectile Dysfunction trials Research Report on Erectile Dysfunction

Trials (filtered) newest first · largest first

All 111 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Efficacy and Safety of HIP2602 in Erectile Dysfunction Patients
HIP2602 + HPP2602-2, HPP2602-1 + HPP2602-2, HGP1201 + HPP2602-1 - Erectile Dysfunction
Phase 3RecruitingHanmi Pharmaceutical Company Limited2252026-10-012026-10-27
The Purpose of This Study is to Evaluate the Efficacy and Safety of W2505.
W2505, W2505-P1, W2505-R - Erectile Dysfunctions
Phase 3Not yet recruitingGL Pharm Tech Corporation2282026-09-012026-10-05
Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction
Umbilical Cord-Derived Mesenchymal Stem Cells, Umblical Cord-Derived Mesenchymal Stem Cell-Derived Exosomes, Placebo Intracavernosal Injection - Erectile Dysfunction With Diabetes Mellitus
Phase 2 / Phase 3RecruitingAnkara City Hospital Bilkent902025-12-292026-03-18
Combination Therapy of Tadalafil 2.5mg Plus Sildenafil 25mg Versus Tadalafil 5 mg Monotherapy for Treatment of Erectile Dysfunction: A Randomized, Placebo-Controlled Double-Blinded Cross-Over Study
Tadalafil 2.5 mg, Sildenafil 25 mg, Tadalafil 5 mg - Erectile Dysfunction
Phase 3Not yet recruitingAssiut University1422025-10-012025-09-24
Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia
DTT106, Dutasteride-Tamsulosin - Prostatic Hyperplasia, Benign, Erectile Dysfunction
Phase 3Not yet recruitingEMS2622025-02-012024-02-20
Actual Use Trial of Tadalafil 5 mg
Tadalafil 5 mg tablets with a digital tool. - Erectile Dysfunction
Phase 3CompletedSanofi22122025-01-302026-07-13
Efficacy and Safety of Toronto Association in the Treatment of Erectile Dysfunction and Premature Ejaculation
Toronto association, Tadalafil, Tadalafil placebo - Erectile Dysfunction, Premature Ejaculation
Phase 3UnknownEMS2322024-07-012023-04-12
Genetic Factors of Erectile Dysfunction Degree and Response to Tadalafil Treatment in Patients With Diabetes
Tadalafil 5mg - Erectile Dysfunction With Diabetes Mellitus
Phase 3UnknownUniversity Medical Centre Ljubljana902024-05-172024-07-25
Long-term Safety of TPN171H Tablet in Erectile Dysfunction.
TPN171H - Erectile Dysfunction
Phase 3CompletedVigonvita Life Sciences4722024-04-122025-07-25
A New Sildenafil Oral Film in Patients With Erectile Dysfunction
Sildenafil Oral Film 25 mg, 50 mg, 75 mg or 100 mg, Placebo - Erectile Dysfunction
Phase 3CompletedIBSA Institut Biochimique SA4882024-01-262025-10-23
Comparsion of Effect of PRP,PDE5 Inhibitor in Treatment of Erectile Dysfunction
Tadalafil 5mg - Erectile Dysfunction
Phase 2 / Phase 3CompletedAin Shams University752024-01-152026-08-12
Efficacy of Intracavernous Platelet-rich Plasma Injection in the Treatment of Erectile Dysfunction
intracavernous platelet rich plasma therapy - Erectile Dysfunction
Phase 3Active not recruitingBakirkoy Dr. Sadi Konuk Research and Training Hospital342023-12-292025-04-24
Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement
Chlorhexidine, Gentamicin, Rifampin - Erectile Dysfunction, Penile Prosthesis; Complications, Infection or Inflammation
Phase 3Active not recruitingRush University Medical Center2002023-12-042026-07-24
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
RALP (Robotic-assisted radical prostatectomy), SAFE (Saline assisted fascial engorgement) - Prostate Cancer, Erectile Dysfunction
Phase 3RecruitingIcahn School of Medicine at Mount Sinai1962023-11-142025-04-25
Efficacy of Tadalafil (5mg) For Treatment of Early Storage Symptoms and Erectile Dysfunction After Endoscopic Enucleation of Prostate
Tadalafil 5mg / Placebo - Erectile Dysfunction, Lower Urinary Tract Symptoms
Phase 2 / Phase 3RecruitingMansoura University1102023-04-012025-06-11
LiST Plus PRP Injection Therapy vs LiST Monotherapy for ED Treatment
LiST + PRP intracorporeal injection, LiST + Placebo(normal saline intracorporeal injection) - Erectile Dysfunction
Phase 2 / Phase 3UnknownInstitute for the Study of Urological Diseases, Greece602022-09-012022-05-09
Effect of Testofen on Erectile Function in an Adult Male Population
Testofen 300mg, Testofen 600mg, Placebo comparator - Erectile Dysfunction
Phase 3CompletedRDC Clinical Pty Ltd642022-04-192026-10-28
Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction.
TPN171H 2.5mg group, TPN171H 5mg group, TPN171H 10mg group - Erectile Dysfunction
Phase 3CompletedVigonvita Life Sciences7652021-12-312023-03-07
Clinical Investigation Using MED3000 Gel or Tadalafil Tablets in the Treatment of Erectile Dysfunction
MED3000 (Male), Tadalafil 5mg (Male), MED3000 (Female) - Erectile Dysfunction
Phase 3CompletedFutura Medical Developments Ltd.1162021-09-142023-09-21
4-aminopyridine Treatment for Nerve Injury
4-Aminopyridine, Placebo - Nerve Injury, Prostate Cancer
Phase 2 / Phase 3RecruitingJohn Elfar702021-06-052025-12-17

Showing 20 of 111. Sign in to see all of them.

Narrower conditions

Sexual Dysfunction, Physiological (11)  ·  Prostatic Neoplasms (7)  ·  Premature Ejaculation (6)  ·  Prostatic Hyperplasia (5)  ·  Diabetes Mellitus (4)  ·  Hypertension (4)  ·  Coitus (3)  ·  Sexual Dysfunctions, Psychological (3)  ·  Hypogonadism (2)  ·  Lower Urinary Tract Symptoms (2)  ·  Spinal Cord Injuries (2)  ·  Depression (1)  ·  Heart Failure (1)  ·  Heart Failure, Systolic (1)

Broader conditions

Genital Diseases (111)  ·  Genital Diseases, Male (111)  ·  Male Urogenital Diseases (111)  ·  Mental Disorders (111)  ·  Urogenital Diseases (111)  ·  Sexual Dysfunctions, Psychological (108)  ·  Sexual Dysfunction, Physiological (100)  ·  Prostatic Diseases (12)  ·  Genital Neoplasms, Male (7)  ·  Neoplasms (7)  ·  Neoplasms by Site (7)  ·  Urogenital Neoplasms (7)  ·  Ejaculatory Dysfunction (6)  ·  Endocrine System Diseases (6)  ·  Cardiovascular Diseases (5)

Interventions

Tadalafil (25)  ·  Vardenafil Dihydrochloride (22)  ·  Sildenafil Citrate (10)  ·  udenafil (6)  ·  avanafil (5)  ·  dapoxetine (5)  ·  2-(5-(4-(2-hydroxyethyl)piperazin-1-ylsulfonyl)-2-n-propoxyphenyl)-5-ethyl-7-n-propyl-3,5-dihydro-4H-pyrrolo(3,2-d)pyrimidin-4-one dihydrochloride (2)  ·  Botulinum Toxins, Type A (2)  ·  Extracorporeal Shockwave Therapy (2)  ·  Tamsulosin (2)  ·  4-Aminopyridine (1)  ·  Alprostadil (1)  ·  Chlorhexidine (1)  ·  Enalapril (1)  ·  Fluvastatin (1)

Sponsors

Bayer (22)  ·  Eli Lilly and Company (13)  ·  Rambam Health Care Campus (9)  ·  VIVUS LLC (4)  ·  EMS (3)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (3)  ·  Warner Chilcott (3)  ·  Dong-A Pharmaceutical Co., Ltd. (2)  ·  Erasmus Medical Center (2)  ·  Futura Medical Developments Ltd. (2)  ·  Hanmi Pharmaceutical Company Limited (2)  ·  JW Pharmaceutical (2)  ·  SK Chemicals Co., Ltd. (2)  ·  Vigonvita Life Sciences (2)  ·  Abdi Ibrahim Ilac San. ve Tic A.S. (1)

Countries

United States (32)  ·  Germany (12)  ·  Israel (9)  ·  Spain (9)  ·  France (8)  ·  Italy (8)  ·  South Korea (8)  ·  Canada (7)  ·  China (6)  ·  Mexico (6)  ·  Netherlands (6)  ·  Australia (5)  ·  Brazil (5)  ·  Poland (5)  ·  Russia (5)

Top investigators

Ilan Gruenwald, MD (4)  ·  Herman Ellman, MD (3)  ·  D G Moon, MD, PhD (2)  ·  D Y Yang, MD, PhD (2)  ·  Hui Jiang (2)  ·  Irwin Goldstein, MD (2)  ·  J J Kim, MD, PhD (2)  ·  J K Park, MD, PhD (2)  ·  J S Paick, MD, PhD (2)  ·  K H Moon, MD, PhD (2)  ·  K S Min, MD, PhD (2)

Results publications

PMID 24119319, PMID 23035781, PMID 20412423, PMID 21059176, PMID 21883954, PMID 19195772, PMID 19878447, PMID 20233275, PMID 20367770, PMID 20456213, PMID 20807322, PMID 20925442, PMID 21707928, PMID 22248153, PMID 22429760, PMID 22790642, PMID 22857780, PMID 23219537, PMID 23521325, PMID 23845016, PMID 24127838, PMID 26299520, PMID 38224135, PMID 38773595, PMID 39434728

NIH funding

2004 (1), 2008 (1), 2009 (1), 2018 (1)